EPOCH-Rrituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EPOCH-Rrituximab, covering 2021-10-19 to 2021-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma [Phase 2]